Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 6
2005 8
2006 3
2007 9
2008 4
2009 9
2010 10
2011 9
2012 24
2013 31
2014 51
2015 47
2016 28
2017 24
2018 41
2019 53
2020 72
2021 64
2022 84
2023 108
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

637 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence.
Liang H, Tsui BY, Ni H, Valentim CCS, Baxter SL, Liu G, Cai W, Kermany DS, Sun X, Chen J, He L, Zhu J, Tian P, Shao H, Zheng L, Hou R, Hewett S, Li G, Liang P, Zang X, Zhang Z, Pan L, Cai H, Ling R, Li S, Cui Y, Tang S, Ye H, Huang X, He W, Liang W, Zhang Q, Jiang J, Yu W, Gao J, Ou W, Deng Y, Hou Q, Wang B, Yao C, Liang Y, Zhang S, Duan Y, Zhang R, Gibson S, Zhang CL, Li O, Zhang ED, Karin G, Nguyen N, Wu X, Wen C, Xu J, Xu W, Wang B, Wang W, Li J, Pizzato B, Bao C, Xiang D, He W, He S, Zhou Y, Haw W, Goldbaum M, Tremoulet A, Hsu CN, Carter H, Zhu L, Zhang K, Xia H. Liang H, et al. Among authors: huang x. Nat Med. 2019 Mar;25(3):433-438. doi: 10.1038/s41591-018-0335-9. Epub 2019 Feb 11. Nat Med. 2019. PMID: 30742121
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial.
Chen L, Jiang YZ, Wu SY, Wu J, Di GH, Liu GY, Yu KD, Fan L, Li JJ, Hou YF, Hu Z, Chen CM, Huang XY, Cao AY, Hu X, Zhao S, Ma XY, Xu Y, Sun XJ, Chai WJ, Guo X, Chen X, Xu Y, Zhu XY, Zou JJ, Yang WT, Wang ZH, Shao ZM. Chen L, et al. Clin Cancer Res. 2022 Jul 1;28(13):2807-2817. doi: 10.1158/1078-0432.CCR-21-4313. Clin Cancer Res. 2022. PMID: 35247906 Free PMC article.
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial.
Fan L, Wang ZH, Ma LX, Wu SY, Wu J, Yu KD, Sui XY, Xu Y, Liu XY, Chen L, Zhang WJ, Jin X, Xiao Q, Shui RH, Xiao Y, Wang H, Yang YS, Huang XY, Cao AY, Li JJ, Di GH, Liu GY, Yang WT, Hu X, Xia Y, Liang QN, Jiang YZ, Shao ZM. Fan L, et al. Lancet Oncol. 2024 Feb;25(2):184-197. doi: 10.1016/S1470-2045(23)00579-X. Epub 2024 Jan 8. Lancet Oncol. 2024. PMID: 38211606 Clinical Trial.
The oral microbiome in autoimmune diseases: friend or foe?
Huang X, Huang X, Huang Y, Zheng J, Lu Y, Mai Z, Zhao X, Cui L, Huang S. Huang X, et al. J Transl Med. 2023 Mar 22;21(1):211. doi: 10.1186/s12967-023-03995-x. J Transl Med. 2023. PMID: 36949458 Free PMC article. Review.
Kidney Function Measures and Mortality: A Mendelian Randomization Study.
Shan Y, Zhang J, Lu Y, Liao J, Liu Y, Dai L, Li J, Song C, Su G, Hägg S, Xiong Z, Nitsch D, Carrero JJ, Huang X. Shan Y, et al. Among authors: huang x. Am J Kidney Dis. 2023 Dec 25:S0272-6386(23)00994-0. doi: 10.1053/j.ajkd.2023.10.014. Online ahead of print. Am J Kidney Dis. 2023. PMID: 38151225 Free article.
miRNAs Regulate hERG.
Lian J, Guo J, Huang X, Yang XI, Huang G, Mao H, Sun HH, Ba Y, Zhou J. Lian J, et al. Among authors: huang x. J Cardiovasc Electrophysiol. 2016 Dec;27(12):1472-1482. doi: 10.1111/jce.13084. Epub 2016 Sep 26. J Cardiovasc Electrophysiol. 2016. PMID: 27558843
637 results